“Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2” (2025) Journal of Tropical Pharmacy and Chemistry, 7(1), pp. 33–40. doi:10.30872/j.trop.pharm.chem.v7i1.148.